ARAIX
Price
$71.75
Change
-$7.24 (-9.17%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

ARAIX vs VSIAX

Header iconARAIX vs VSIAX Comparison
Open Charts ARAIX vs VSIAXBanner chart's image
Ariel Fund Institutional
Price$71.75
Change-$7.24 (-9.17%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
ARAIX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ARAIX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAIX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. ARAIX (2.83B). VSIAX pays higher dividends than ARAIX: VSIAX (2.01) vs ARAIX (0.65). ARAIX was incepted earlier than VSIAX: ARAIX (13 years) vs VSIAX (13 years). ARAIX is a more actively managed with annual turnover of: 20.00 vs. VSIAX (16.00). VSIAX has a lower initial minimum investment than ARAIX: VSIAX (3000) vs ARAIX (1000000). ARAIX (16.90) and VSIAX (16.23) have marching annual gain over last year. VSIAX return over 5 years is better than : 52.83 vs. ARAIX (25.59).
ARAIXVSIAXARAIX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD15.58415.031104%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets2.83B63B4%
Annual Yield % from dividends0.652.0132%
Returns for 1 year16.9016.23104%
Returns for 3 years-0.4220.67-2%
Returns for 5 years25.5952.8348%
Returns for 10 years17.61105.6517%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics